bw 12c79 has been researched along with mitomycin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedford, P; Bleehen, NM; Dennis, I; Falk, SJ; Nethersell, AB; Ramsay, JR; Ward, R; Wootton, R; Workman, P | 1 |
| Bleehen, NM; Dixon, AK; Falk, SJ; Miles, K; Ramsay, JR; Ward, R | 1 |
| Carmichael, J; Dennis, I; Ganesan, T; Mitchell, K; Philip, PA; Rajagopalan, B; Rea, D; Stuart, NS; Taylor, DJ; Thompson, CH | 1 |
| Bleehen, NM; Dennis, IF; Ramsay, JR; Workman, P | 1 |
| Braybrooke, JP; Dixon, RM; Ganesan, TS; Harris, AL; Levitt, NC; Littlewood, TJ; O'Byrne, K; Propper, DJ; Rajagopalan, B; Talbot, DC; Thompson, CH | 1 |
5 trial(s) available for bw 12c79 and mitomycin
| Article | Year |
|---|---|
Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzaldehydes; Drug Evaluation; Gastrointestinal Neoplasms; Hemoglobins; Humans; Middle Aged; Mitomycin; Oxygen | 1992 |
BW12C perturbs normal and tumour tissue oxygenation and blood flow in man.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzaldehydes; Cohort Studies; Erythrocytes; Gastrointestinal Neoplasms; Hemoglobins; Humans; Hypoxia; Laser-Doppler Flowmetry; Mitomycin; Muscle, Skeletal; Oxygen; Oxygen Consumption; Oxyhemoglobins; Regional Blood Flow; Skin; Tomography, X-Ray Computed | 1994 |
A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopy.
Topics: Adult; Aged; Benzaldehydes; Drug Therapy, Combination; Female; Hemoglobins; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Mitomycin; Muscles; Neoplasms; Oxygen | 1993 |
Pharmacokinetics of BW12C and mitomycin C, given in combination in a phase 1 study in patients with advanced gastrointestinal cancer.
Topics: Benzaldehydes; Drug Combinations; Drug Evaluation; Gastrointestinal Neoplasms; Half-Life; Humans; Metabolic Clearance Rate; Mitomycin; Neoplasm Metastasis | 1993 |
Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer.
Topics: Adult; Aged; Benzaldehydes; Cell Hypoxia; Colorectal Neoplasms; Drug Synergism; Drug Therapy, Combination; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Oxygen | 2000 |